Fujii, K.; Yamamoto, Y.; Mizutani, Y.; Saito, K.; Seishima, M.
Indoleamine 2,3-Dioxygenase 2 Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation. Int. J. Mol. Sci. 2020, 21, 5515.
https://doi.org/10.3390/ijms21155515
AMA Style
Fujii K, Yamamoto Y, Mizutani Y, Saito K, Seishima M.
Indoleamine 2,3-Dioxygenase 2 Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation. International Journal of Molecular Sciences. 2020; 21(15):5515.
https://doi.org/10.3390/ijms21155515
Chicago/Turabian Style
Fujii, Kento, Yasuko Yamamoto, Yoko Mizutani, Kuniaki Saito, and Mariko Seishima.
2020. "Indoleamine 2,3-Dioxygenase 2 Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation" International Journal of Molecular Sciences 21, no. 15: 5515.
https://doi.org/10.3390/ijms21155515
APA Style
Fujii, K., Yamamoto, Y., Mizutani, Y., Saito, K., & Seishima, M.
(2020). Indoleamine 2,3-Dioxygenase 2 Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation. International Journal of Molecular Sciences, 21(15), 5515.
https://doi.org/10.3390/ijms21155515